Scientists have developed a drug called STM2457 which inhibits a key enzyme involved in acute myeloid leukaemia.
List view / Grid view
University of Cambridge
For the first time, scientists have grown bile duct organoids that could repair damaged ducts and livers as a new cell therapy.
A team has revealed how SARS-CoV-2 infects cells, suggesting that targeting its RNA with drugs would stop the virus replicating.
A study has identified more than 200 genes that drive the progression of glioblastoma and which the researchers say present drug targets.
Researchers have developed a video and model-building programme for other scientists to build full-length COVID-19 S protein models.
Two studies reveal the importance of timing in Huntington’s disease interventions and demonstrate interleukin-6 may play a protective role.
Scientists have designed a high affinity antibody for pathogenic amyloid beta oligomers, a key driver of Alzheimer’s disease, for use in further research and as a potential diagnostic tool.
Researchers have created ‘three-parent flies' which can be used as a model to study mitochondrial diseases and screen potential drug compounds.
Researchers have used whole genome sequencing to analyse breast cancers and reveal which are more responsive to treatments, which could improve the development of oncologic therapies.
A research team has developed a method for regenerating old brain stem cells from rat models, which could be used to treat age-related brain diseases.
A new technique called ‘ubiquitin clipping’ has been created which could aid proteomics research and the development of new drugs for ubiquitination.
A combination of heart cells derived from human stem cells could lead to developing a treatment for heart failure.
A new study has identified a molecule which targets a protein linked with Parkinson’s.